Treatment of severe inflammatory eye disease in patients of reproductive age and during pregnancy

Ocular Immunology and Inflammation

Volumn 20, Issue 4, 2012, Pages 277-287

  Wakefield, Denis ^a   El Asrar, Ahmed Abu ^b   McCluskey, Peter ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Infertility; Pregnancy; Therapy; Veitis

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; RECOMBINANT ALPHA2 INTERFERON; RITUXIMAB; TACROLIMUS;

AMENORRHEA; ARTICLE; AZOOSPERMIA; BONE MARROW SUPPRESSION; CONGENITAL MALFORMATION; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EAR MALFORMATION; EYE INFLAMMATION; HUMAN; INFERTILITY; IRIDOCYCLITIS; LOW DRUG DOSE; LYMPHOCYTOPENIA; MALE INFERTILITY; OLIGOSPERMIA; PREGNANCY; PRENATAL EXPOSURE; REPRODUCTION; SCLERITIS; SYSTEMATIC REVIEW; UVEITIS;

FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UVEITIS;

EID: 84864332271     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2012.684736     Document Type: Article

References (86)

1. Motta M, Tincani A, Lojacono A, et al. Neonatal outcome in patients with rheumatic disease. Lupus. 2004;13:718-723. (Pubitemid 39279791)
2. Ostensen M. Disease specific problems related to drug therapy in pregnancy. Lupus. 2004;13:746-750. (Pubitemid 39279796)
3. Rabiah PK, Vitale AT, Rabiah PK, Vitale AT. Noninfectious uveitis and pregnancy. Am J Ophthalmol. 2003;136:91-98. (Pubitemid 36794500)
4. Kump LI, Cervantes C, Xoo F, et al. Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium. Ocul Immunol Inflamm. 2006;14:99-104.
5. Chan CC, Reed GF, Kim Y, et al. A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis. Br J Ophthalmol. 2004;88:1506-1509. (Pubitemid 39573585)
6. Agarwal RK, Chan CC, Wiggert B, Caspi RR. Pregnancy ameliorates induction and expression of experimental autoimmune uveitis. J Immunol. 1999;162:2648-2654. (Pubitemid 29309285)
7. Zhu WH, Lu CZ, Huang YM, Link H, Xiao BG. A putative mechanism on remission of multiple sclerosis during pregnancy: Estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells. Mult Scler. 2007;13:33-40. (Pubitemid 46152759)
8. Keeling SO, Oswald AE, Keeling SO, Oswald AE. Pregnancy and rheumatic disease: "by the book" or "by the doc." Clin Rheumatol. 2009;28:1-9.
9. Ostensen M. Treatment with immunosuppressive and disease modifying drugs during pregnancy and lactation. Am J Reprod Immunol. 1992;28:148-152. (Pubitemid 23044817)
10. Temprano KK, Bandlamudi R, Moore TL, Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheumatism. 2005;35:112-121. (Pubitemid 41356587)
11. Ostensen M, von Esebeck M, Villiger PM, Ostensen M, von Esebeck M, Villiger PM. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. J Rheumatol. 2007;34:1266-1269. (Pubitemid 46898107)
12. Mersereau J, Dooley MA. Gonadal failure with cyclophosphamide therapy for lupus nephritis: Advances in fertility preservation. Rheum Dis Clin North Am. 2010;36:99-108, viii.
13. Ostensen M, Ramsey-Goldman R. Treatment of inflammatory rheumatic disorders in pregnancy: What are the safest treatment options? Drug Safety. 1998;19:389-410. (Pubitemid 28505197)
14. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385-392.
15. Skomsvoll JF, Ostensen M, Irgens LM, Baste V. Obstetrical and neonatal outcome in pregnant patients with rheumatic disease. Scand J Rheumatol Suppl. 1998;107:109-112. (Pubitemid 28432958)
16. Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A. Safety and efficacy of disease-modifying anti-rheumatic agents: Focus on the benefits and risks of etanercept. Drug Safety. 2002;25:173-197. (Pubitemid 34492938)
17. Mogadam M, Dobbins WO, 3rd, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: Effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology. 1981;80:72-76. (Pubitemid 11213291)
18. Mogadam M, Korelitz BI, Ahmed SW, Dobbins WO, 3rd, Baiocco PJ. The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol. 1981;75:265-269. (Pubitemid 11086914)
19. Elliott AB, Chakravarty EF, Elliott AB, Chakravarty EF. Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases. Women's Health. 2010;6:431-440; quiz 41-42.
20. Ostensen M, Orger F, Nelson JL, Schuhmacher A, Hebisch G, Villiger PM. Pregnancy in patients with rheumatic disease: Anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheumatic Dis. 2005;64:839-844. (Pubitemid 40733905)
21. Jap A, Chee SP. Immunosuppressive therapy for ocular diseases. Curr Opin Ophthalmol. 2008;19:535-540.
22. Grunnet E, Nyfors A, Hansen KB. Studies of human semen in topical corticosteroid-treated and in methotrexate-treated psoriatics. Dermatologica. 1977;154:78-84. (Pubitemid 8069372)
23. Martinez Lopez JA, Loza E, Carmona L. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). Clin Exp Rheumatol. 2009;27:678-684.
24. Ostensen M, Hartmann H, Salvesen K. Low dose weekly methotrexate in early pregnancy: A case series and review of the literature. J Rheumatol. 2000;27:1872-1875. (Pubitemid 30670480)
25. Bermas BL, Hill JA. Effects of immunosuppressive drugs during pregnancy. Arthritis Rheumatism. 1995;38:1722-1732. (Pubitemid 26010272)
26. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med. 2000;160:610-619. (Pubitemid 30140410)
27. Ostensen M. Counselling women with rheumatic disease-how many children are desirable? Scand J Rheumatol. 1991;20:121-126.
28. Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheumatism. 1997;40:971-973. (Pubitemid 27200016)
29. Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal AM. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med. 1990;88:589-592. (Pubitemid 20192270)
30. Mottet C, Juillerat P, Pittet V, et al. Pregnancy and breastfeeding in patients with Crohn's disease. Digestion. 2007;76: 149-160. (Pubitemid 351194910)
31. Feldkamp M, Carey JC. Clinical teratology counseling and consultation case report: Low dose methotrexate exposure in the early weeks of pregnancy. Teratology. 1993;47:533-539. (Pubitemid 23172495)
32. Elliott AB, Chakravarty EF, Elliott AB, Chakravarty EF. Management of rheumatic diseases during pregnancy. Postgrad Med. 2010;122:213-221.
33. Cao ZG, Liu JH, Zhu YP, et al. [Effects of different immunodepressants on the sperm parameters of kidney transplant recipients]. Zhonghua Nan Ke Xue. 2006;12:405-407.
34. Ostensen M, Lockshin M, Doria A, et al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology (Oxford). 2008;47 (Suppl 3):iii28-31.
35. Enns GM, Roeder E, Chan RT, Ali-Khan Catts Z, Cox VA, Golabi M. Apparent cyclophosphamide (cytoxan) embryopathy: A distinct phenotype? Am J Med Genet. 1999;86:237-241. (Pubitemid 29465869)
36. le Gallez P. Teratogenesis and drugs for rheumatic disease. Nursing Times. 1988;84:41-44.
37. Ostesen M. Optimisation of antirheumatic drug treatment in pregnancy. Clin Pharmacokinet. 1994;27:486-503.
38. Steege JF, Caldwell DS. Renal agenesis after first trimester exposure to chlorambucil. South Med J. 1980;73:1414-1415. (Pubitemid 11015301)
39. Liu L, Prasad SC, Bassano DA, Heavern J, Keshler B, Hahn SS. A dwell position verification method for high dose rate brachytherapy. J Appl Clin Med Phys. 2004;5:1-5.
40. Botta JA, Jr., Hawkins HC, Weikel JH, Jr. Effects of cyclophosphamide on fertility and general reproductive performance of rats. Toxicol Appl Pharmacol. 1974;27:602-611.
41. Anchan RM, Ginsburg ES. Fertility concerns and preservation in younger women with breast cancer. Crit Rev Oncol Hematol. 2010;74:175-192.
42. Wang CL, Wang F, Bosco JJ. Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus. Lupus. 1995;4:11-14.
43. Kainz A, Harabacz I, Cowlrick IS, Gadgil S, Hagiwara D. Analysis of 100 pregnancy outcomes in women treated systemically with tacrolimus. Transpl Int. 2000;13Suppl 1: S299-S300.
44. Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation. 2000;70: 1718-1721. (Pubitemid 32064826)
45. Deuter CM, Zierhut M, Mohle A, Vonthein R, Stobiger N, Kotter I. Long-term remission after cessation of interferonalpha treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum. 2010;62:2796-2805.
46. Kuemmerle-Deschner JB, Tzaribachev N, Deuter C, Zierhut M, Batra M, Koetter I. Interferon-alpha-a new therapeutic option in refractory juvenile Behçet's disease with CNS involvement. Rheumatology (Oxford). 2008;47:1051-1053. (Pubitemid 351865931)
47. McGuire JL. The endocrine system and connective tissue disorders. Bull Rheum Dis. 1990;39:1-8.
48. Munoz-Fernandez S, Hidalgo V, Fernandez-Melon J, et al. Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period. J Rheumatol. 2003;30:1277-1279. (Pubitemid 36666354)
49. Huang JL, Hung IJ, Hsieh KH. Sulphasalazine therapy in chronic uveitis of children with chronic arthritis. Asian Pac J Allergy Immunol. 1997;15:71-75.
50. Hoo JJ, Hadro TA, Von Behren P. Possible teratogenicity of sulfasalazine. N Engl J Med. 1988;318:1128. (Pubitemid 18098615)
51. Guignard S, Gossec L, Salliot C, et al. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: A retrospective study. Ann Rheum Dis. 2006;65:1631-1634. (Pubitemid 44799677)
52. Simonini G, Cantarini L, Bresci C, Lorusso M, Galeazzi M, Cimaz R. Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev. 2010;9:674-683.
53. Farvardin M, Afarid M, Mehryar M, Hosseini H. Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis. Retina. 2010;30:1530-1535.
54. Ostensen M, Lockshin M, Doria A, et al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology (Oxford). 2008;47 (Suppl 3):iii28-31.
55. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: Evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255-1258. (Pubitemid 44512222)
56. Rosner I, Haddad A, Boulman N, et al. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)- alpha therapy. Rheumatology (Oxford). 2007;46:1508; author reply -9. (Pubitemid 47317106)
57. Chambers CD, Tutuncu ZN, Johnson D, Jones KL. Human pregnancy safety for agents used to treat rheumatoid arthritis: Adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther. 2006;8:215.
58. Onal S, Kazokoglu H, Koc A, Yavuz S. Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis. Ocul Immunol Inflamm. 2008;16:230-232.
59. Davatchi F, Shams H, Rezaipoor M, et al. Rituximab in intractable ocular lesions of Behçet's disease; randomized single-blind control study (pilot study). Int J Rheum Dis. 2010;13:246-252.
60. Geissal ED, Wernick R. A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab. J Clin Rheumatol. 2010;16:185-187.
61. Vinet E, Pineau C, Gordon C, Clarke AE, Bernatsky S. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum. 2009;61:587-592.
62. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr. 1972;81:936-945.
63. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet. 1999;86:242-244. (Pubitemid 29465870)
64. Lockshin MD, Sammaritano LR. Corticosteroids during pregnancy. Scand J Rheumatol Suppl. 1998;107:136-8. (Pubitemid 28432965)
65. Rayburn WF. Glucocorticoid therapy for rheumatic diseases: Maternal, fetal, and breast-feeding considerations. Am J Reprod Immunol. 1992;28:138-140. (Pubitemid 23044815)
66. Sauk J, Kane S. The use of medications for inflammatory bowel disease during pregnancy and nursing. Expert Opin Pharmacother. 2005;6:1833-1839. (Pubitemid 41358421)
67. Ost L, Wettrell G, Bjorkhem I, Rane A. Prednisolone excretion in human milk. J Pediatr. 1985;106:1008-1011. (Pubitemid 15006657)
68. Needs CJ, Brooks PM. Antirheumatic medication during lactation. Br J Rheumatol. 1985;24:291-297. (Pubitemid 15226494)
69. Polifka JE, Friedman JM. Teratogen update: Azathioprine and 6-mercaptopurine. Teratology. 2002;65:240-261. (Pubitemid 34492613)
70. Goldstein LH, Dolinsky G, Greenberg R, et al. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Res A Clin Mol Teratol. 2007;79:696-701. (Pubitemid 47584193)
71. Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn's disease and birth outcomes: A Danish nationwide cohort study. Am J Gastroenterol. 2007;102:1406-1413. (Pubitemid 46976292)
72. Sau A, Clarke S, Bass J, Kaiser A, Marinaki A, Nelson-Piercy C. Azathioprine and breastfeeding: Is it safe? BJOG. 2007;114:498-501.
73. Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF. National Transplantation Pregnancy Registry-outcomes of 154 pregnancies in cyclosporinetreated female kidney transplant recipients. Transplantation. 1994;57:502-506. (Pubitemid 24075792)
74. Nyberg G, Haljamae U, Frisenette-Fich C, Wennergren M, Kjellmer I. Breast-feeding during treatment with cyclosporine. Transplantation. 1998;65:253-255. (Pubitemid 28099220)
75. Cassoux N, Goichot-Bonnat L, Karmochkine M, et al. [Efficacy of intravenous immunoglobulin in the treatment of birdshot retinochoroiditis]. J Fr Ophtalmol. 2002;25:23-30. (Pubitemid 34123536)
76. Onal S, Foster CS, Ahmed AR. Efficacy of intravenous immunoglobulin treatment in refractory uveitis. Ocul Immunol Inflamm. 2006;14:367-374. (Pubitemid 44949896)
77. Stephenson MD, Kutteh WH, Purkiss S, et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: A multicentered randomized placebo-controlled trial. Hum Reprod. 2010;25:2203-2209.
78. Lazarus AH. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity. J Clin Immunol. 2010;30(Suppl 1): S20-S23.
79. Friedman DM, Llanos C, Izmirly PM, et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum. 2010;62:1138-1146.
80. Hemady RK, Chan AS, Nguyen AT. Immunosuppressive agents and nonsteroidal anti-inflammatory drugs for ocular immune and inflammatory disorders. Ophthalmol Clin North Am. 2005;18:511-528, vi. (Pubitemid 41728020)
81. Levinson RD, Rosenbaum JT. Nonsteroidal anti-inflammatory drugs for prophylaxis of acute anterior uveitis. Ocul Immunol Inflamm. 2010;18:69-71.
82. Stone S, Khamashta MA, Nelson-Piercy C. Nonsteroidal antiinflammatory drugs and reversible female infertility: Is there a link? Drug Safety. 2002;25:5455-5451.
83. Dawood MY. Nonsteroidal antiinflammatory drugs and reproduction. Am J Obstet Gynecol. 1993;169:1255-1265. (Pubitemid 24001650)
84. American Academy of Pediatrics Committee on Drugs: The transfer of drugs and other chemicals into human milk. Pediatrics. 1994;93:137-150.
85. Treatment of rheumatoid arthritis: Unknown long-term effects. Prescrire Int. 2001;10:55-61.
86. Stutz G, Martini AC, Ruiz RD, Fiol De Cuneo M, Munoz L, Lacuara JL. Functional activity of mouse sperm was not affected by low doses of aspirin-like drugs. Arch Androl. 2000;44:117-128.(Pubitemid 30159903)